Here are four key points:
1. Zimmer Biomet anticipates full-year adjusted earnings per share of $7.90 to $8. This estimate surpasses the company’s previous forecast of $7.85 to $8 per share.
2. The company expects 2016 revenue to hit between $7.68 billion and $7.72 billion.
3. Zimmer Biomet experienced a net loss of $31.3 million for the quarter ending June 30.
4. The company’s second quarter earnings hit $2.02 per share, an increase from $1.58 for the same period a year prior.
More articles on devices:
Orthofix’s PHOENIX MIS Fixation System receives regulatory clearance in Japan: 5 things to know
Smith & Nephew’s NAVIO system used to implant JOURNEY II total knee devices in TKR procedure: 4 key points
Zimmer Biomet reports Q2 sales jump 65%; Net loss at $31.1M: 10 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
